| F2 | F3 | ||||||
---|---|---|---|---|---|---|---|---|
F2 patient group | Age-adjusted mean or ratio of standard group | F3 patient group | Age-adjusted mean or ratio of standard group | |||||
n | Mean or ratio | 95% CI | n | mean or ratio | 95% CI | |||
Body mass index (BMI, kg/m2) | 130 | 24.1* | 23.2–24.9 | 23.1 | 43 | 22.9 | 21.3–24.4 | 23.2 |
 Male | 56 | 24.7 | 23.4–26.1 | 23.9 | 19 | 21.7* | 19.9–23.5 | 23.8 |
 Female | 74 | 23.6* | 22.5–24.7 | 22.5 | 24 | 23.8 | 21.3–26.2 | 22.8 |
Waist circumference (cm) | 119 | 85.2 | 82.7–87.6 | 82.9 | 39 | 83.6 | 79.2–88.1 | 84.3 |
 Male | 51 | 88.5 | 84.8–92.3 | 86.0 | 16 | 82.8 | 76.4–89.3 | 86.7 |
 Female | 68 | 82.6 | 79.4–85.9 | 80.5 | 23 | 84.2 | 77.7–90.6 | 82.6 |
Systolic blood pressure (mmHg) | 144 | 125.3 | 122.6–127.9 | 126 | 45 | 131.6 | 126.1–137.1 | 132.8 |
 Male | 62 | 127.5 | 123.4–131.6 | 128.4 | 20 | 131.5 | 122.8–140.2 | 134.9 |
 Female | 82 | 123.5 | 120.1–127.0 | 124.2 | 25 | 131.7 | 124.1–139.3 | 131.2 |
Diastolic blood pressure (mmHg) | 144 | 77.2 | 75.3–79.1 | 79.0 | 45 | 77.0 | 73.7–80.4 | 80.1 |
 Male | 62 | 80.4 | 77.6–83.1 | 82.0 | 20 | 77.1* | 72.5–81.6 | 82.7 |
 Female | 82 | 74.8 | 72.3–77.2 | 76.7 | 25 | 77.0 | 71.9–82.1 | 78.1 |
Hypertension | 144 | 0.271 | 0.200–0.351 | 0.349 | 45 | 0.467 | 0.317–0.621 | 0.555 |
 Male | 62 | 0.355 | 0.237–0.487 | 0.367 | 20 | 0.450 | 0.231–0.685 | 0.590 |
 Female | 82 | 0.207* | 0.126–0.311 | 0.336 | 25 | 0.480 | 0.278–0.687 | 0.527 |
Diabetes mellitus | 144 | 0.160* | 0.104–0.230 | 0.089 | 45 | 0.156 | 0.065––0.295 | 0.145 |
 Male | 62 | 0.194 | 0.104–0.314 | 0.105 | 20 | 0.100 | 0.012–0.317 | 0.193 |
 Female | 82 | 0.134 | 0.069–0.227 | 0.077 | 25 | 0.200 | 0.068–0.407 | 0.106 |
High LDL-cholesterolemia | 140 | 0.264 | 0.193–0.345 | 0.241 | 44 | 0.364 | 0.224–0.522 | 0.252 |
 Male | 60 | 0.283 | 0.175–0.414 | 0.237 | 19 | 0.211 | 0.061–0.456 | 0.215 |
 Female | 80 | 0.250 | 0.160–0.359 | 0.244 | 25 | 0.480 | 0.278–0.687 | 0.280 |
Low HDL-cholesterolemia | 139 | 0.209* | 0.144–0.286 | 0.073 | 44 | 0.205* | 0.098–0.353 | 0.092 |
 Male | 59 | 0.322* | 0.206–0.456 | 0.134 | 19 | 0.316 | 0.126–0.566 | 0.155 |
 Female | 80 | 0.125* | 0.062–0.218 | 0.028 | 25 | 0.120 | 0.026–0.312 | 0.044 |
Hypertriglyceridemia | 143 | 0.210* | 0.146–0.286 | 0.331 | 44 | 0.205* | 0.098–0.353 | 0.354 |
 Male | 62 | 0.258* | 0.155–0.385 | 0.446 | 19 | 0.158* | 0.034–0.396 | 0.436 |
 Female | 81 | 0.173 | 0.098–0.273 | 0.243 | 25 | 0.240 | 0.094–0.451 | 0.292 |
Metabolic syndrome | 115 | 0.209* | 0.141–0.294 | 0.123 | 38 | 0.263 | 0.130–0.421 | 0.190 |
 Male | 49 | 0.306* | 0.191–0.459 | 0.180 | 15 | 0.200 | 0.041–0.457 | 0.283 |
 Female | 66 | 0.136 | 0.062–0.236 | 0.068 | 23 | 0.304* | 0.132–0.529 | 0.125 |
Prevalence of smoking | 139 | 0.396* | 0.314–0.482 | 0.237 | 40 | 0.125 | 0.042–0.268 | 0.176 |
 Male | 61 | 0.541* | 0.409–0.669 | 0.395 | 16 | 0.188 | 0.041–0.457 | 0.326 |
 Female | 78 | 0.282* | 0.186–0.395 | 0.113 | 24 | 0.083 | 0.010–0.270 | 0.076 |
Ratio of SBI and cerebral infarction | 141 | 0.234* | 0.155–0.297 | 0.141 | 44 | 0.477* | 0.325–0.633 | 0.304 |